Malignite Potansiyeli Belirsiz Ürotelyal Proliferasyon

Reuter, V.E., Algaba, F., Amin, M.B., et al. (2016) Non-invasive Urothelial Lesions. In Holger Moch, Thomas M. Ulbright, Victor E. Reuter, (Eds.), WHO Classification of Tumours of the Urinary System and Male Genital Organs. (4 ed., pp. 99-107). France: International Agency for Research on Cancer (IARC)

Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol. 2005;13(2):143-153. doi:10.1177/106689690501300203

Khani F, Robinson BD. Precursor Lesions of Urologic Malignancies. Arch Pathol Lab Med. 2017;141(12):1615-1632. doi:10.5858/arpa.2016-0515-RA

Koss LG, Tiamson EM, Robbins MA. Mapping Cancerous and Precancerous Bladder Changes: A Study of the Urothelium in Ten Surgically Removed Bladders. JAMA. 1974;227(3):281–286. doi:10.1001/jama.1974.03230160009002

Taylor DC, Bhagavan BS, Larsen MP, et al. Papillary urothelial hyperplasia: A precursor to papillary neoplasms. American Journal of SurgicalPathology.1996;20(12):1481-1488. https://doi.org/10.1097/00000478-199612000-00007

Jacobs JB, Arai M, Cohen SM, et al. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res. 1977;37(8 Pt 2):2817-2821.

Bryan GT. The pathogenesis of experimental bladder cancer. Cancer Res 1977; 37: 2813–2816.

Czerniak B, Li L, Chaturvedi V, et al. Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer. 2000;27(4):392-402.

Hartmann A, Schlake G, Zaak D, et al. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res. 2002;62(3):809-818.

Chow NH, Cairns P, Eisenberger CF, et al. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer. 2000;89(6):514-518.

Readal N, Epstein JI. Papillary urothelial hyperplasia: relationship to urothelial neoplasms. Pathology. 2010;42(4):360-363. doi:10.3109/00313021003767322

Samaratunga H, Makarov DV, Epstein JI. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology. 2002;60(2):315-319. doi:10.1016/s0090-4295(02)01705-3

Hodges KB, Lopez-Beltran A, Davidson DD, et al. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. Hum Pathol. 2010;41(2):155-162. doi:10.1016/j.humpath.2009.07.002

Lopez-Beltran A, Montironi R, Vidal A, et al. Urothelial dysplasia of the bladder: diagnostic features and clinical significance. Anal Quant Cytopathol Histpathol. 2013;35(3):121-129.

Lane Z, Epstein JI. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia. Am J Surg Pathol. 2008;32(5):758-764. doi:10.1097/PAS.0b013e31816092b5

Netto GJ. Molecular diagnostics in urologic malignancies: a work in progress. Arch Pathol Lab Med. 2011;135(5):610-621. doi:10.1043/2010-0727-RAIR.1

Netto GJ. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?. Adv Anat Pathol. 2013;20(3):175-203. doi:10.1097/PAP.0b013e3182863f80

Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol. 2006;24(35):5552-5564. doi:10.1200/JCO.2006.08.2073

Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer. 2005;5(9):713-725. doi:10.1038/nrc1697

Küçükodacı Z, Yörükoğlu K. Mesane Ürotelyal Kanserlerinin Tanısal Prognostik, Moleküler Özellikleri ve Yeni Tedavi Yaklaşımları. Bulletin of Urooncology. 2015;14:258-270. DOI: 10.4274/uob.366

Hartmann A, Moser K, Kriegmair M, et al. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol. 1999;154(3):721-727. doi:10.1016/S0002-9440(10)65318-7

Reznikoff CA, Sarkar S, Jülicher KP, et al. Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol. 2000;5(5):191-203. doi:10.1016/s1078-1439(00)00079-x

van Oers JM, Adam C, Denzinger S, et al. Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder. Int J Cancer. 2006;119(5):1212-1215. doi:10.1002/ijc.21958

Obermann EC, Junker K, Stoehr R, et al. Frequent genetic alterations in nat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. J Pathol. 2003;199:59-7. https://doi.org/10.1002/path.1259